Trials
Characteristics of race/ethnicity in trials leading to anti‐rheumatic drug approval for inflammatory arthritis by the US Food and Drug Administration
…the approved drugs and demographic data for each pivotal trial, especially the race/ethnicity data, were collected. The enrollment profiles ...
Diversity in clinical trials in Europe and the US: a review of a pharmaceutical company's data collection, reporting, and interpretation of race an...
Editorial
. 2023 Sep 27;S0923-7534(23)03945-5.
doi: 10.1016/j.annonc.2023.09.3107.
Online ahead of print.
...
5 Reasons It’s Important for People of Color to Take Part in Clinical Trials
Newswise — To become part of the standard of care in doctors’ offices and hospitals and to be covered by health insurance, new medications and proc...
White House Highlights Programs by TOUCH, The Black Breast Cancer Alliance, Involving Breast Cancer Clinical Trials For Black Women
TOUCH BBCA commits to reaching 350,000 Black women and motivating 25,000 into trial portals through innovative programming
WASHINGTON–(BUSINESS ...
Reporting and Representation of Participant Race and Ethnicity in National Institutes of Health–Funded Pediatric Clinical Trials | Equity, Diversit...
Key Points
Question
To what extent are participant race and ethnicity reported in publications and ClinicalTrials.gov, and how representa...
Collection of Race and Ethnicity Data in Clinical Trials
Docket Number:
FDA-2016-D-3561
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research
Center for Devices and Radiological He...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
